ASKA Pharmaceutical Holdings (4886) · TargetRestated
Optimizing Management Across the Group and Maximizing Group Value
First written in FY2022-Q1. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Group Growth Strategy, Optimal Allocation of Management Resources and Maximization of SynergiesA theme 81 companies write about · 0 as a headwind · 86 as a tailwind
32 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 81 companies compared. The sentences above are computed from all 81.Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「While taking into account the characteristics of each business, we will emphasize strategic collaboration among Group companies, pursue optimal management from a Group-wide perspective and maximize Group value.」
グループ会社間の連携を通じた全体最適とグループ価値最大化の方針を再掲している。 - FY2022-Q1First statedAnnual report
「While taking into account the characteristics of each business, we will emphasize strategic collaboration among Group companies, pursue optimal management from a Group-wide perspective and maximize Group value.」
The objective is to achieve optimal management and maximize Group value through strategic collaboration among Group companies.